Tongkat Ali (4:1) Extract Capsules contain a botanical extract derived from the root of Eurycoma longifolia Jack, commonly known as Tongkat Ali or Longjack. The plant is native to Southeast Asia and its root has a long history of traditional use.
MEDIOCON INC offers Tongkat Ali extract capsules for suitable nutraceutical, dietary-supplement and men's wellness applications, subject to the final formulation, product specification and regulatory requirements of the target market.
Tongkat Ali is a botanical ingredient primarily obtained from the roots of Eurycoma longifolia. Its characteristic phytochemicals include quassinoids, with eurycomanone being an important analytical marker, together with glycosaponins and other naturally occurring constituents.
A 4:1 extract generally indicates that approximately four parts of the starting botanical material were used to produce one part of extract. However, extraction ratio alone does not establish the concentration of individual bioactive constituents. The final potency should therefore be confirmed through analytical testing and the product CoA.
Product Name: Tongkat Ali (4:1) Extract Capsules
Botanical Name: Eurycoma longifolia Jack
Common Names: Tongkat Ali / Longjack
Plant Part: Root
Extract Ratio: 4:1
Category: Botanical Nutraceutical Ingredient
Dosage Form: Capsule
Application: Men's Wellness / Nutraceutical Supplement
Tongkat Ali (Eurycoma longifolia Jack) is a plant belonging to the Simaroubaceae family. The root is the principal plant material used in traditional preparations and commercial extracts.
Tongkat Ali root contains several classes of naturally occurring phytochemicals, including:
Eurycomanone is one of the principal quassinoids used as a marker compound in analytical characterization of Eurycoma longifolia extracts.
Tongkat Ali extract is commonly incorporated into:
Commercial supplement labels commonly position Tongkat Ali around male vitality and wellness.
Tongkat Ali has traditionally been used in Southeast Asian herbal practices, particularly in preparations associated with men's vitality and general wellness.
Modern research has investigated Eurycoma longifolia for several aspects of human health, but results depend on the specific extract, dose, standardization and study design.
The 4:1 designation describes the relationship between the starting botanical material and the resulting extract.
For example, conceptually:
4 kg raw dried root → approximately 1 kg extract
However, the actual extraction process can affect the final phytochemical composition. Therefore:
4:1 does not mean 4× the eurycomanone content.
For commercial quality control, an HPLC assay for eurycomanone and other relevant markers is preferable to relying on extraction ratio alone.
Eurycomanone is a naturally occurring quassinoid found in Eurycoma longifolia roots and is frequently used as a marker compound for standardized Tongkat Ali extracts.
Do not publish a specific eurycomanone percentage for your 4:1 product unless it is supported by your actual CoA.
MEDIOCON INC can supply Tongkat Ali 4:1 Extract Capsules according to an agreed finished-product specification.
Quality documentation may include:
Tongkat Ali 4:1 Extract may be incorporated into:
The actual capsule fill weight and serving size should be based on the final formulation and validated product specification.
Store capsules in a cool, dry place, protected from excessive heat, humidity and direct sunlight.
Keep the container tightly closed when not in use.
The actual storage requirements and shelf life should follow the validated finished-product specification.
Potential commercial packaging formats include:
Final packaging should be selected according to stability requirements and target-market regulations.
Tongkat Ali requires particular attention to extract identity, standardization and safety assessment. EFSA evaluated a specific standardized Eurycoma longifolia root extract proposed for use as a novel food and concluded that its safety had not been established under the proposed conditions, citing findings related to potential DNA damage in the submitted toxicological studies. This assessment concerned the specific standardized extract evaluated by EFSA and should not automatically be treated as a conclusion about every Tongkat Ali preparation.
For this reason, MEDIOCON should publish only the dosage, claims and safety information supported by the exact formulation and target-market regulatory assessment.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Tongkat Ali (4:1) Extract Capsules Manufacturer & Supplier in India | MEDIOCON INC and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Tongkat Ali (4:1) Extract Capsules Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance